{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T22:57:32Z","timestamp":1769813852192,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.jneuroim.2006.04.005","type":"journal-article","created":{"date-parts":[[2006,7,17]],"date-time":"2006-07-17T21:27:50Z","timestamp":1153171670000},"page":"201-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a"],"prefix":"10.1016","volume":"177","author":[{"given":"M.","family":"Tatsumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Odaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Yuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2006.04.005_bib1","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1212\/WNL.53.9.2122","article-title":"Rapidly progressive, predominantly motor Guillain-Barr\u00e9 syndrome with anti-GalNAc-GD1a antibodies","volume":"53","author":"Ang","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2006.04.005_bib3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/mus.10424","article-title":"Axonal pharyngeal\u2013cervical\u2013brachial variant of Guillain-Barr\u00e9 syndrome without anti-GT1a IgG antibody","volume":"28","author":"Arai","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2006.04.005_bib2","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2006.04.005_bib4","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1074\/jbc.275.6.3896","article-title":"Biosynthesis of ganglioside mimics in Campylobacter jejuni OH4384: identification of the glycosyltransferase genes, enzymatic synthesis of model compounds, and characterization of nanomole amounts by 600\u00a0MHz 1H and 13C NMR analysis","volume":"275","author":"Gilbert","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2006.04.005_bib6","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/1531-8249(199906)45:6<758::AID-ANA10>3.0.CO;2-N","article-title":"Anti-GalNAc-GD1a antibody-associated Guillain-Barr\u00e9 syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance","volume":"45","author":"Hao","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2006.04.005_bib5","doi-asserted-by":"crossref","first-page":"8144","DOI":"10.1016\/S0021-9258(19)39049-0","article-title":"Isolation and characterization of extremely minor gangliosides, GM1b and GD1\u03b1, in adult bovine brains as developmentally regulated antigens","volume":"265","author":"Hirabayashi","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2006.04.005_bib7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/118.3.597","article-title":"Guillain-Barr\u00e9 syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies","volume":"118","author":"Ho","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2006.04.005_bib8","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00415-003-1114-0","article-title":"Acute oropharyngeal palsy associated with anti-GM1b IgG antibody","volume":"250","author":"Ikuta","year":"2003","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2006.04.005_bib9","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1016\/S0021-9258(18)68935-5","article-title":"Gangliosides GM2, IV4GalNAcGM1b, and IV4GalNAcGD1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy","volume":"263","author":"Ilyas","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2006.04.005_bib10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/brain\/123.1.116","article-title":"Guillain-Barr\u00e9 syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a","volume":"123","author":"Kaida","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2006.04.005_bib11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0165-5728(00)00451-3","article-title":"Guillain-Barr\u00e9 syndrome with IgM antibody to the ganglioside GalNAc-GD1a","volume":"113","author":"Kaida","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2006.04.005_bib12","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/(SICI)1097-4598(200005)23:5<702::AID-MUS6>3.0.CO;2-A","article-title":"Chronic motor axonal neuropathy associated with antibodies monospecific for N-acetylgalactosaminyl GD1a","volume":"23","author":"Kaji","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2006.04.005_bib13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0165-5728(98)00016-2","article-title":"Is IgG anti-GT1a antibody associated with pharyngeal\u2013cervical\u2013brachial weakness or oropharyngeal palsy in Guillain-Barr\u00e9 syndrom\u00e9?","volume":"86","author":"Koga","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2006.04.005_bib14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/jnnp.66.4.513","article-title":"Antiganglioside antibody in patients with Guillain-Barr\u00e9 syndrome who show bulbar palsy as an initial symptom","volume":"66","author":"Koga","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2006.04.005_bib15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.72.6.767","article-title":"Anti-GT1a IgG in Guillain-Barr\u00e9 syndrome","volume":"72","author":"Koga","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2006.04.005_bib16","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1212\/01.WNL.0000160399.08456.7C","article-title":"Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry","volume":"64","author":"Koga","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2006.04.005_bib17","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.410350510","article-title":"N-Acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barr\u00e9 syndrome","volume":"35","author":"Kusunoki","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2006.04.005_bib18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1212\/WNL.47.1.237","article-title":"GM1b is a new member of [sic] antigen for serum antibody in Guillain-Barr\u00e9 syndrome","volume":"47","author":"Kusunoki","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2006.04.005_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-510X(02)00088-6","article-title":"Hyperreflexia axonal Guillain-Barr\u00e9 syndrome subsequent to Campylobacter jejuni enteritis","volume":"199","author":"Kuwabara","year":"2002","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2006.04.005_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/01.WNL.0000133205.05169.04","article-title":"Does Campylobacter jejuni infection elicit \u201cdemyelinating\u201d Guillain-Barr\u00e9 syndrome","volume":"63","author":"Kuwabara","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2006.04.005_bib21","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/mus.10122","article-title":"Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1a antibodies","volume":"25","author":"Lopate","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2006.04.005_bib22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jns.2003.09.008","article-title":"Bickerstaff's brainstem encephalitis associated with IgM antibodies to GM1b and GalNAc-GD1a","volume":"217","author":"Matsuo","year":"2004","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2006.04.005_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jns.2004.01.005","article-title":"Clinical correlates of serum anti-GT1a IgG antibodies","volume":"219","author":"Nagashima","year":"2004","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2006.04.005_bib24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/jnnp.70.1.50","article-title":"Anti-GQ1b IgG antibody syndrome: clinical and immunological range","volume":"70","author":"Odaka","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2006.04.005_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00415-004-0259-9","article-title":"Ataxic Guillain-Barr\u00e9 syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies","volume":"251","author":"Odaka","year":"2004","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2006.04.005_bib26","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O","article-title":"Axonal Guillain-Barr\u00e9 syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan","volume":"48","author":"Ogawara","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2006.04.005_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-510X(03)00013-3","article-title":"Anti-GM1b IgG antibody is associated with acute motor axonal neuropathy and Campylobacter jejuni infection","volume":"15","author":"Ogawara","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2006.04.005_bib28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0165-5728(01)00373-3","article-title":"IgM monoclonal antibody against terminal moiety of GM2: GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release","volume":"119","author":"Ortiz","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2006.04.005_bib29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0008-6215(91)80011-B","article-title":"Regio- and stereo-selective synthesis of ganglioside GM1b and some positional analogs","volume":"220","author":"Prabhanjan","year":"1991","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.jneuroim.2006.04.005_bib30","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","article-title":"Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)","volume":"41","author":"Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2006.04.005_bib31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000062988","article-title":"High anti-GM1 and anti-GD1a antibody titers are detected in Guillain-Barr\u00e9 syndrome but not in chronic inflammatory demyelinating polyneuropathy","volume":"48","author":"Tagawa","year":"2002","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jneuroim.2006.04.005_bib32","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2006.04.005_bib33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(96)00142-7","article-title":"Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barr\u00e9 syndrome subsequent to Campylobacter jejuni enteritis","volume":"71","author":"Yuki","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2006.04.005_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0165-5728(96)00201-9","article-title":"Close association of Guillain-Barr\u00e9 syndrome with antibodies to minor monosialogangliosides GM1b and GM1\u03b1","volume":"74","author":"Yuki","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2006.04.005_bib35","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ana.410430424","article-title":"Preserved tendon reflexes in Campylobacter neuropathy","volume":"43","author":"Yuki","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2006.04.005_bib36","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/1531-8249(200003)47:3<314::AID-ANA6>3.0.CO;2-C","article-title":"Clinical features and response to treatment in Guillain-Barr\u00e9 syndrome associated with antibodies to GM1b ganglioside","volume":"47","author":"Yuki","year":"2000","journal-title":"Ann. Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572806001354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572806001354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:03:56Z","timestamp":1759046636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572806001354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0165572806001354"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2006.04.005","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2006.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}